IDEAYA Biosciences Announces Submission of IND Application for MAT2A Development Candidate IDE397 with the U S FDA

Monday, January 11, 2021 1 min read

Key Takeaway: IDEAYA Biosciences Announces Submission of IND Application for MAT2A Development Candidate IDE397 with the U S FDA

Full Press Release Details

IDEAYA Biosciences Announces Submission of IND Application for MAT2A Development Candidate IDE397 with the U S FDA.